Clinical evidence on the use of brodalumab for the treatment of psoriasis in Greece: Experience from clinical practice of four tertiary hospitals-Reference-Cited by-同舟云学术

Clinical evidence on the use of brodalumab for the treatment of psoriasis in Greece: Experience from clinical practice of four tertiary hospitals

Published:2022-05-30 Issue:7 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Tampouratzi Eleftheria¹,Papakonstantis Markos²,Katsantonis John¹,Sidiropoulos Theodoros³,Delli Florentina³^ORCID,Efthymiadis Konstantinos³,Sfaelos Konstantinos⁴^ORCID,Christodoulou Athina⁵,Chasapi Vasiliki⁵,Panagakis Pantelis⁵

Affiliation:

1. Dermatological Department Tzaneio General Hospital Piraeus Greece

2. Clinic of Dermatology 401 General Military Hospital of Athens Athens Greece

3. State Dermatology Department Hippokratio General Hospital of Thessaloniki Thessaloniki Greece

4. LEO Pharma Hellas, Dermatology Kifissia Greece

5. Department of Dermatology and Venereology NHS Andreas Syggros Hospital Athens Greece

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15532

Reference32 articles.

1. Psoriasis: epidemiology, clinical features, and quality of life

2. Psoriasis Pathogenesis and Treatment

3. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study

4. Diagnosis and classification of psoriasis

5. Update on psoriasis immunopathogenesis and targeted immunotherapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest;Journal of Dermatological Treatment;2024-04-18

2. Real‐world data on the effectiveness of brodalumab in patients with moderate‐to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study);Journal of the European Academy of Dermatology and Venereology;2024-02-03

3. Drug survival, effectiveness, and safety of brodalumab for moderate‐to‐severe psoriasis up to 3 years;International Journal of Dermatology;2024-01-29

4. Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population;Australasian Journal of Dermatology;2023-07-12

5. Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis;Drugs in R&D;2023-05-08